CAS: 2968-93-6; 2-(4-(Trifluoromethyl)Phenyl)Ethanol

该化合物是有机化合物,其结构特征包括一个由三氟甲基组和乙醇混合物替代的苯环,该化合物通常具有芳香和酒精功能的特性,包括因氢氧(OH)组而具有的中度极性,三氟甲基组的存在会增加其脂度,并可能影响其反应和与生物系统的互动,经常用于有机合成,并可作为生产药品或农用化学品的一个中间体,该化合物的物理特性,如沸点和溶解性,可因环境条件和其他溶剂的存在而有所不同,此外,由于三氟甲基组,该化合物可能具有独特的电子特性,从而对材料科学和医药化学具有兴趣,在处理和储存方面应参考安全数据,对任何化学物质而言也是如此.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号32857-62-8 4-(三氟甲基)苯乙酸 | CAS号135325-18-7 2-(4-(三氟甲基)苯基)乙酸甲酯 | CAS号30934-62-4 4-三氟甲基苯乙醛 | CAS号130365-87-6 4-(三氟甲基)苯乙基溴 | CAS号402-50-6 4-(三氟甲基)苯乙烯 | CAS号41360-55-8 2-[4-(三氟甲基)苯基]乙酰胺 | CAS号402-45-9 4-(三氟甲基)苯酚 | CAS号107-21-1 乙二醇 | CAS号75-21-8 环氧乙烷 | CAS号26416-26-2 4-methylbenzene... | CAS号30934-62-4 4-三氟甲基苯乙醛 | CAS号130365-87-6 4-(三氟甲基)苯乙基溴 | CAS号178685-14-8 1-(2-iodoethyl)...

合成工艺路线路线简述

    4-(三氟甲基)苄醇置于锂硼氢,戴斯-马丁氧化剂,Sodium Hydroxide体系中,用 异丙醇 用作溶剂,化学反应生成4-(三氟甲基)苯乙醇
    参考文献:伯醇的单碳认证和涉及 Jocic 型反应的醛的还原认证
    标题:伯醇的单碳认证和涉及 Jocic 型反应的醛的还原认证
    摘要:(三氯甲基)甲醇在一次操作中由醇或醛形成,可在涉及 Libh4 的 Jocic 型反应中转化为伯醇.最终结果是方便的两步,伯醇的单碳同源或醛的还原性单碳同源,具有广泛的底物范围.该方法是步骤经济的,它很好地补充了已建立的单碳同源策略.
    Doi:10.1002/ejoc.201501089

    海关参考信息

    专利信息


    专利号:US-11161827-B2
    优先权日:2019-04-05
    标 题 :Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination
    发明人:Zhang xiao-xiang; Lang kai
    权利人:TRUSTEES BOSTON COLLEGE; THE TRUSTEES OF BOSTON COLLEGE
    摘要:In one aspect, the disclosure relates to a mode of asymmetric induction in radical processes based on sequential combination of enantiodifferentiative H-atom abstraction and stereoretentive radical substitution. Also disclosed is an asymmetric system for stereoselective synthesis of strained 5-membered cyclic sulfamides via radical 1,5-C—H amination of sulfamoyl azides. The disclosed metalloradical system can control the degree and sense of asymmetric induction in the catalytic radical C—H amination in a systematic manner. The disclosed system is applicable to a broad scope of substrates with different types of C(sp 3 )—H bonds and exhibits reactivity and selectivity, providing access to both enantiomers of useful 5-membered cyclic sulfamides in a highly enantioenriched form. Also disclosed are catalysts useful in these processes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

    专利号:US-2020317627-A1
    优先权日:2019-04-05
    标 题:Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical c-h amination

    专利号:US-2005240034-A1
    优先权日:2002-05-07
    标 题 :Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
    发明人:AVERY MITCHELL; MURALEEDHARAN KANNOTH M
    权利人:AVERY MITCHELL; MURALEEDHARAN KANNOTH M
    摘要:Described herein is the synthesis, bioassay results and utility of new C- 9 and C- 10 substituted artemisinin derivatives with easily functionalizable groups attached to the artemisinin skeleton through carbon chain or heteroatoms. Described also is the demonstration of this class of compounds for their broad-spectrum anti-parasitic activity. Certain of these analogs possess noticeable cytotoxicity deliberately focused on treatment of cancerous diseases.
    上海威远精细氟科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shwychem.com
    企业联系电话:021-64251386 64253204👤
    📞上海威远精细氟科技发展有限公司 ⚠️参考联系方式

    电话:021-64251386 64253204

    传真:021-64253354
    邮箱:wdchen@shwychem.com
    通信地址: 上海梅陇路130号华东理工科技大楼
    邮编: 200237
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海梅陇路130号华东理工科技大楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南大宇化工有限公司控股公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司控股公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com
    通信地址: 济南市济阳区济北生命科技园
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市济阳区济北生命科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题: Sphingosine Kinase Inhibitors Inhibiteurs De La Sphingosine Kinase
    摘要:Sphingosine Kinases Are Enzymes That Catalyze The Biosynthesis Of Sphingosine-1-Phosphate. The Invention Provides Compounds That Are Effective For Inhibition Of Sphingosine Kinase Type 1, Sphingosine Kinase Type 2, Or Both. Certain Compounds Are Selective For Sphingosine Kinase Type 2 Relative To Sphingosine Kinase Type 1. Compounds Of The Invention Can Be Used In Treatment Of A Range Of Diseases Wherein Increasing The Level Of Sphingosine-1-Phosphate In Blood Is Medically Indicated. Diseases That Can Be Treated By Administration Of An Effective Dose Of A Compound Of The Invention Include A Neoplastic Disease That Involves Excess Vascular Growth; Macular Degeneration Or Diabetic Retinopathy; An Allergic Disease Such As Asthma, An Inflammatory Disease Of The Eye Such As Uveitis, Scleritis, Or Vitritis; An Inflammatory Disease Of The Kidney; A Fibrotic Disease; Atherosclerosis; Or Pulmonary Arterial Hypertension. A Compound Of The Invention Can Be Used To Improve The Integrity Of A Vascular Barrier In A Disease Where The Vascular Barrier Is Disrupted, Such As Cancer Or Alzheimer'S Disease.

    合成参考文献


    摘要:Treacy, S. M.; Zhang, X.; Rovis, T., Science of Synthesis, (2021) , 627.
    摘要:Chen, P.; Liu, G., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 44.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知